Skiadopoulos M H, Surman S R, Durbin A P, Collins P L, Murphy B R
Respiratory Viruses Section, Bethesda, Maryland 20892, USA.
Virology. 2000 Jun 20;272(1):225-34. doi: 10.1006/viro.2000.0372.
Recombinant parainfluenza virus 3 (rPIV3) is being developed as a vector to express foreign genes as a bivalent or multivalent live attenuated virus vaccine. In the present study, we examined the effect of inserted foreign sequence on virus replication in vitro and in vivo, focusing on the parameter of insert length. In one type of construct, foreign sequence of increasing length was flanked by PIV3 transcription signals and inserted as an additional gene unit (GU insert) between the HN and L genes, so that one additional mRNA would be made. In a second type of construct, foreign sequence was inserted into the downstream NCR (NCR insert) of the HN gene, so that the number of encoded mRNAs remained unchanged. In each case, the foreign sequence was designed to lack any significant open reading frame, which permitted an evaluation of the effect of insert length on replication independent of an effect of an expressed protein. The GU or NCR insert sizes ranged from 168 nucleotides (nt) to 3918 nt. rPIV3s containing GU insertions of up to 3918 nt in length, the largest size tested, were viable and replicated efficiently at permissive temperatures in vitro, but a reduction in plaque size was seen at 39 degrees C and 40 degrees C. The rPIV3 with a 3918-nt GU insertion was restricted in replication in the upper (fivefold) and lower (25-fold) respiratory tracts of hamsters. Although a 1908-nt GU insertion did not significantly modify replication of wild-type PIV3 in vitro or in vivo, its introduction significantly augmented the level of temperature sensitivity (ts) and attenuation (att) specified by three mutations in the L protein of a cold-passaged attenuated PIV3 vaccine virus. rPIV3s bearing a 3126- or 3894-nt NCR insertion exhibited in vitro and in vivo phenotypes like those of the rPIV3s bearing similar-sized GU insertions. These findings indicate that rPIV3s whose genome length has been increased by more than 3000 nt by either a GU or an NCR insertion exhibit an unexpected host-range phenotype, that is, efficient replication in vitro but restricted replication in hamsters, especially in the lower respiratory tract. Furthermore, these effects were greatly enhanced when the rPIV3 backbone contained other ts or att mutations. The implications of these findings for the use of single-stranded, negative-sense RNA viruses as vectors for vaccines are discussed.
重组副流感病毒3型(rPIV3)正被开发为一种载体,用于表达外源基因,作为二价或多价减毒活病毒疫苗。在本研究中,我们研究了插入的外源序列对病毒在体外和体内复制的影响,重点关注插入长度参数。在一种构建体中,长度不断增加的外源序列两侧是PIV3转录信号,并作为一个额外的基因单元(GU插入)插入HN和L基因之间,这样就会产生一个额外的mRNA。在第二种构建体中,外源序列插入HN基因的下游非编码区(NCR插入),使得编码的mRNA数量保持不变。在每种情况下,外源序列被设计为缺乏任何显著的开放阅读框,这使得可以独立于表达蛋白的影响来评估插入长度对复制的影响。GU或NCR插入片段的大小范围从168个核苷酸(nt)到3918 nt。含有长达3918 nt(测试的最大长度)GU插入的rPIV3在体外允许的温度下是可行的且能高效复制,但在39℃和40℃时可见噬斑大小减小。带有3918 nt GU插入的rPIV3在仓鼠的上呼吸道(五倍)和下呼吸道(25倍)的复制受到限制。尽管1908 nt的GU插入在体外或体内并未显著改变野生型PIV3的复制,但其引入显著提高了冷传代减毒PIV3疫苗病毒L蛋白中三个突变所确定的温度敏感性(ts)和减毒(att)水平。带有3126 nt或3894 nt NCR插入的rPIV3在体外和体内的表型与带有类似大小GU插入的rPIV3相似。这些发现表明,通过GU或NCR插入使基因组长度增加超过3000 nt的rPIV3表现出意想不到的宿主范围表型,即体外高效复制但在仓鼠中复制受限,尤其是在下呼吸道。此外,当rPIV3骨架包含其他ts或att突变时,这些影响会大大增强。讨论了这些发现对于使用单链负义RNA病毒作为疫苗载体的意义。